equityflowunderstand the flow and follow it

Ultromics

Healthtech · Oxford, GB

AI health tech for echocardiography-based detection of heart failure and cardiac amyloidosis.

Founders

Ross Upton (United Kingdom · ♂) — While doing a PhD in cardiovascular medicine at Oxford as a sonographer, he saw AI could overcome the limitations of traditional echocardiography and, with Professor Paul Leeson, built an algorithm that became EchoGo and spun out Ultromics in 2017.
Paul Leeson (United Kingdom · ♂) — As an Oxford cardiology professor supervising Ross Upton's research, he co-founded Ultromics to commercialize the AI echocardiography work developed in his lab.

Date	Round	Amount
Jul 2025	Series C Ultromics raised a $55M Series C led by Lightrock, L&G and Allegis Capital to expand its AI heart-disease diagnostics.	$55M
Aug 2021	Series B Oxford cardiology-AI company Ultromics raised a USD 33M Series B led by the Blue Venture Fund.	$33M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.